These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 466656)

  • 41. Characterization of L1210 cell growth inhibition by the bacterial iron chelators parabactin and compound II.
    Cavanaugh PF; Porter CW; Tukalo D; Frankfurt OS; Pavelic ZP; Bergeron RJ
    Cancer Res; 1985 Oct; 45(10):4754-9. PubMed ID: 4027962
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors.
    Garibjanian BT; Johnson RK; Kline I; Vadlamudi S; Gang M; Venditti JM; Goldin A
    Cancer Treat Rep; 1976 Sep; 60(9):1347-61. PubMed ID: 797450
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Melanin synthesis and the action of L-dopa and 3,4-dihydroxybenzylamine in human melanoma cells.
    Kable EP; Parsons PG
    Cancer Chemother Pharmacol; 1989; 23(1):1-7. PubMed ID: 2909284
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sequential inhibitory effects of antitumor agents related to levodopa and dopamine upon DNA synthetic enzymes.
    Fitzgerald GB; Wick MM
    Biochem Pharmacol; 1986 Jan; 35(2):271-5. PubMed ID: 3510622
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of ribonucleotide reductase by antitumor agents related to levodopa and dopamine.
    FitzGerald GB; Wick MM
    Biochem Pharmacol; 1985 Feb; 34(3):353-60. PubMed ID: 3882092
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antitumor effects of biologic reducing agents related to 3,4-dihydroxybenzylamine: dihydroxybenzaldehyde, dihydroxybenzaldoxime, and dihydroxybenzonitrile.
    Wick MM; FitzGerald GB
    J Pharm Sci; 1987 Jul; 76(7):513-5. PubMed ID: 3312571
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dopamine: a novel antitumor agent active against B-16 melanoma in vivo.
    Wick MM
    J Invest Dermatol; 1978 Aug; 71(2):163-4. PubMed ID: 681787
    [TBL] [Abstract][Full Text] [Related]  

  • 48. L-Threonine deaminase as a possible antitumor agent.
    Wellner D; Greenfield RS
    Cancer Treat Rep; 1979 Jun; 63(6):1089-94. PubMed ID: 466649
    [TBL] [Abstract][Full Text] [Related]  

  • 49. L-Dopa methyl ester: prolongation of survival of neuroblastoma-bearing mice after treatment.
    Wick MM
    Science; 1978 Feb; 199(4330):775-6. PubMed ID: 622565
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Levodopa/dopamine analogs as inhibitors of DNA synthesis in human melanoma cells.
    Wick MM
    J Invest Dermatol; 1989 May; 92(5 Suppl):329S-331S. PubMed ID: 2715667
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 7-substituted actinomycin D analogs. Chemical and growth-inhibitory studies.
    Sengupta SK; Tinter SK; Lazarus H; Brown BL; Modest EJ
    J Med Chem; 1975 Dec; 18(12):1175-80. PubMed ID: 1059773
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antitumor activity of some microbial and chemical transformation products of anguidine (4,15-diacetoxyscirpene-3-ol).
    Claridge CA; Schmitz H; Bradner WT
    Cancer Chemother Pharmacol; 1979; 2(3):181-2. PubMed ID: 455572
    [TBL] [Abstract][Full Text] [Related]  

  • 53. l-Dopa methyl ester as a new antitumour agent.
    Wick MM
    Nature; 1977 Oct; 269(5628):512-3. PubMed ID: 909598
    [No Abstract]   [Full Text] [Related]  

  • 54. The effect of l-dopa and alpha-methyl-dopa on C cell secretion in the thyroid gland.
    Zabel M; WarchoĊ‚ JB
    Acta Med Pol; 1977; 18(4):387-90. PubMed ID: 24984
    [No Abstract]   [Full Text] [Related]  

  • 55. Effect of AC-3579, a diazafluoranthen derivative, on murine leukemia P388 and L1210--I. In vivo study.
    Hildebrand J; Thys O; Atassi G; Debusscher L; Tagnon HJ
    Eur J Cancer (1965); 1973 Sep; 9(9):635-9. PubMed ID: 4279175
    [No Abstract]   [Full Text] [Related]  

  • 56. Experimental and clinical studies on nucleoside analogs as antitumor agents.
    Burchenal JH; Currie VE; Dowling MD; Fox JJ; Krakoff IH
    Ann N Y Acad Sci; 1975 Aug; 255():202-12. PubMed ID: 1059355
    [No Abstract]   [Full Text] [Related]  

  • 57. In vitro antiproliferative activity of 2'-(2-hydroxyphenyl)-2'-thiazoline-4'-carboxylic acid and its methyl ester on L1210 and P388 murine neoplasms.
    Elliot GT; Kelly KF; Bonna RL; Wardlaw TR; Burns ER
    Cancer Chemother Pharmacol; 1988; 21(3):233-6. PubMed ID: 3359557
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Experimental antileukemic agents. Coralyne, analogs, and related compounds.
    Zee-Cheng KY; Paull KD; Cheng CC
    J Med Chem; 1974 Mar; 17(3):347-51. PubMed ID: 4811233
    [No Abstract]   [Full Text] [Related]  

  • 59. Synthesis and some properties and antitumor effects of the actinomycin lactam analog, (di(1-L-alpha, beta-diaminopropionic))actinomycin D1.
    Moore S; Patel RP; Atherton E; Kondo M; Meienhofer J
    J Med Chem; 1976 Jun; 19(6):766-72. PubMed ID: 950643
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Catecholamine analogs as potential antitumor agents.
    Driscoll JS
    J Pharm Sci; 1979 Dec; 68(12):1519-21. PubMed ID: 529042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.